Union Pacific Faces Scrutiny After Deadly Smuggling Incident on Texas Rail Line NexGel NXGL Q1 2026 Results Miss Estimates EPS 011 vs 007 Perfect PERF Q1 2026 Earnings Beat Revenue NA EPS 002 SEBI Eases InvIT Borrowing Norms Enhances Flexibility for Completed Project SPVs Mercury Reaches 52 Billion Valuation in Latest Funding Round Signaling Resilience in Fintech Sector Bond Markets Signal Inflation Concerns as New Fed Leadership Emerges Trump Advises Caution in Iran Negotiations as Strait of Hormuz Reopening Considered US and China Remain Divided on Trade Following TrumpXi Summit APEC Talks Show UK Police to Score Train Operators on Sexual Harassment Response No Financial Penalties for NonCompliance Prediction Markets Flag IonQ Micron Anduril as Potential Next US Government Equity Stakes NFG Q1 2026 Earnings EPS Falls Short of Consensus Stock Dips Slightly RLJ Lodging Trust Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Discipline Supports Results Cable One Inc CABO Q1 2026 Earnings EPS Surpasses Estimates Amid Unreported Revenue Origin Bancorp Inc OBK Q1 2026 Earnings EPS Misses Estimates Despite Solid Operational Performance HWBK Q1 2026 Earnings Solid EPS Performance Amidst Cautious Market Reception CEVA Q1 2026 Earnings EPS Surprises by 122 Amid Strong Licensing Momentum AMD Surges 778 as Semiconductor Giant Breaks Key Resistance Levels Regency Centers Preferred Stock REGCP Slips 105 as Yield Appeal Faces Rate Headwinds Rand Capital RAND Sees a 15 Upswing as Shares Approach Key Resistance Bluerock Homes Trust BHM Edges Higher Navigating Support and Resistance at 1062 NMFCZ Holds Steady FixedIncome Note Maintains Stability Amid Market Uncertainty OpenAI Hires ServiceNow CMO Fleming to Lead Business Marketing Expansion World Cup Campaigns Shaping Consumer Choices in Food Fashion and Travel Microsofts Anthropic Partnership Could Deliver 43 Billion Azure Revenue by 2030 HSBC Estimates World Bank Data Highlights Automation Risk 69 of Jobs in India Could Be Threatened Tesla Stock Consolidates in Tight Range as Recovery From Deep Lows Continues AIEnhanced Drug Discovery May Accelerate Development of Treatments for Neurological Conditions LightPath Technologies Q1 2026 Earnings EPS Misses Estimates Yet Stock Surges 187 Bolt Biotherapeutics BOLT Slips 12 as Shares Test Key Support at 465